Cargando…
High expression of integrin β6 in association with the Rho–Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers
Integrin αvβ6 is involved in the transition from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) of the breast. In addition, integrin β6 (ITGB6) is of prognostic value in invasive breast cancers, particularly in HER2+ subtype. However, pathways mediating the activity of integrin α...
Autores principales: | Desai, Krisha, Nair, Madhumathy G., Prabhu, Jyothi S., Vinod, Anupama, Korlimarla, Aruna, Rajarajan, Savitha, Aiyappa, Radhika, Kaluve, Rohini S., Alexander, Annie, Hari, P. S., Mukherjee, Geetashree, Kumar, Rekha V., Manjunath, Suraj, Correa, Marjorrie, Srinath, B. S., Patil, Shekhar, Prasad, M. S. N., Gopinath, K. S., Rao, Raman N., Violette, Shelia M., Weinreb, Paul H., Sridhar, T. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873607/ https://www.ncbi.nlm.nih.gov/pubmed/27184932 http://dx.doi.org/10.1002/cam4.756 |
Ejemplares similares
-
Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer
por: Korlimarla, Aruna, et al.
Publicado: (2016) -
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease
por: Prabhu, Jyothi S, et al.
Publicado: (2017) -
The Impact of Breast Cancer on the Patient and the Family in Indian Perspective
por: Alexander, Annie, et al.
Publicado: (2019) -
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors
por: Prabhu, Jyothi S., et al.
Publicado: (2014) -
miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis
por: Nair, Madhumathy G, et al.
Publicado: (2020)